CLPT

ClearPoint Neuro Inc.

Price

$14.15

return (12m)

38.05%

p/e

-13.49

p/bv

43.25

DIVIDEND YIELD

0.00%

CLPT price

ClearPoint Neuro

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CLPT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

8.85%

3 months

9.78%

1 year

38.05%

2 years

12.12%

5 years

-27.47%

10 years

145.66%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CLPT

Valuation

P/E

-13.49

Sector -0.30

Industry -3.74

P/BV

43.25

Sector 1.88

Industry 1.32

P/Revenue (PSR)

11.03

Sector 1.62

Industry 2.27

EV/EBITDA

Sector -56.73

Industry -38.51

EV/EBIT

Sector -495.32

Industry -61.92

P/EBITDA

Sector -192.31

Industry -39.83

P/EBIT

Sector -230.06

Industry -59.07

P/Total Assets

5.37

Sector 0.90

Industry 0.86

P/Net Current Assets

-17.24

Sector -24.09

Industry -82.44

P/Working Capital

12.07

Sector -5.12

Industry -6.69

EPS

-1.15

Sector -0.78

Industry -1.25

BVPS

0.36

Sector 3.80

Industry 2.23

Efficiency

Gross Margin

62.61%

Sector 48.34%

Industry 49.22%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -20,100,387.98%

EBIT Margin

0.00%

Sector -62.93%

Industry -18,749,058.89%

Operating Margin

-73.42%

Sector -22.73%

Industry -30.01%

Net Profit Margins

-81.76%

Sector -27.03%

Industry -32.63%

Asset Turnover

0.13

Sector 0.13

Industry 0.06

Profitability

ROE

-320.69%

Sector -30.72%

Industry -44.11%

ROA

-39.85%

Sector -28.03%

Industry -50.97%

ROIC

0.00%

Sector -317.33%

Industry -162.60%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.75

Sector 1.85

Industry 2.38

Net Debt / EBITDA

Sector -42.45

Industry -15.77

Net Debt / EBIT

Sector -37.26

Industry -71.89

Net Debt / Equity

4.66

Sector -1.04

Industry -1.11

Gross Debt / Equity

4.66

Sector -0.72

Industry -0.54

Equity/Assets

0.12

Sector 0.44

Industry 0.49

Liabilities/Assets

0.88

Sector 0.48

Industry 0.44

Growth

5Y Revenue CAGR

21.02%

Sector -

Industry -

5Y Earnings CAGR

19.13%

Sector -

Industry -

Fundamentals CLPT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CLPT ClearPoint Neuro Inc.	$14.15	35.67%	0.00%	-13.49	43.25	-320.69%	-81.76%
ISRG Intuitive Surgical Inc.	$368.37	-21.47%	0.00%	41.68	7.19	17.26%	28.62%
ABT Abbott Laboratories	$108.56	-15.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.44	3.06%	3.15%	24.14	2.31	9.59%	13.20%
BSX Boston Scientific Corp.	$47.00	-55.93%	0.00%	16.90	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$86.32	-22.62%	0.00%	21.17	6.20	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$530.26	-17.08%	0.00%	38.35	27.10	70.67%	25.03%
RMD ResMed Inc.	$229.58	-14.20%	1.01%	22.70	5.31	23.41%	27.44%
COHR Coherent Inc.	$267.30	204.44%	0.00%	118.60	4.87	4.11%	6.85%
SYK Stryker Corp.	$309.96	-19.49%	1.07%	33.63	5.23	15.55%	14.43%
PHG Koninklijke Philips NV	$25.99	-0.19%	3.79%	19.71	1.93	9.80%	6.30%
INMD InMode Ltd.	$14.83	2.91%	0.00%	11.29	1.39	12.32%	20.69%
DXCM DexCom Inc.	$89.56	20.54%	0.00%	34.58	13.19	38.14%	20.12%
EW Edwards Lifesciences Corp.	$89.61	9.59%	0.00%	51.78	4.85	9.36%	15.41%
BDX Becton Dickinson and Company	$186.97	2.37%	2.23%	54.97	2.12	3.86%	6.30%
ALGN Align Technology Inc.	$158.41	15.49%	0.00%	27.43	2.68	9.77%	9.99%
IRMD iRadimed Corporation	$86.37	21.97%	1.45%	49.47	11.21	22.66%	26.71%
SNN Smith & Nephew PLC	$28.65	-19.72%	2.69%	10.82	2.35	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CLPT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ClearPoint Neuro

ClearPoint Neuro Inc.

Average Investor10 user rating

4.0 (1 people)

United States

28 years

Founded: 1998

2012

Time since IPO - 14 years

67

Employees

ClearPoint Neuro Inc. (United States) is listed on the Nasdaq and has a market capitalization of $466.20 million, with shareholders equity totaling $10.78 million.

The company employs approximately 67 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, ClearPoint Neuro Inc. reported $42.28 million in revenue, generating net income of $-34.57 million.

Key financial metrics include a P/E ratio of -13.49, a price-to-book (P/B) ratio of 43.25, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CLPT.

Market cap

$466.20 million

Net worth

$10.78 million

$10,780,000.00

Assets

$86.74 million

$86,740,000.00

Total Shares Outstanding

30.00 million

30,000,000

Average Daily Trading Volume

$657.33 Thousand

$657,330.12

Sector

Health

Industry

Medical Supplies and Equipment

CLPT

CLPT revenue and profits

Financial Results CLPT

DRAG THE FRAME TO SEE MORE DATA

CLPT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$97.84 37,65% (12M)

P/E

-0.84

2.84%

ROE

-178.93%

P/BV

1.50

CI - Cigna

$284.92 --2,55% (12M)

P/E

10.72

2.21%

ROE

16.04%

P/BV

1.72

CNC - Centene

$68.28 127,15% (12M)

P/E

-6.23

0.00%

ROE

-22.56%

P/BV

1.40

HUM - Humana

$412.33 34,08% (12M)

P/E

36.19

0.91%

ROE

6.72%

P/BV

2.43

SNY - Sanofi

$44.30 --7,70% (12M)

P/E

7.29

3.94%

ROE

18.43%

P/BV

1.34

LLY - Eli Lilly

$1,154.74 60,15% (12M)

P/E

39.01

0.55%

ROE

P/BV

HCA - HCA Healthcare

$409.57 1,14% (12M)

P/E

11.79

0.72%

ROE

-244.72%

P/BV

-28.86

NVS - Novartis

$162.77 29,40% (12M)

P/E

27.32

2.03%

ROE

27.47%

P/BV

7.50